Exit
Portfolio company Faeth Therapeutics completed NASDAQ listing (ticker: FTH) with $200M PIPE in February 2026.
Faeth Therapeutics
JUN 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Faeth Therapeutics
Reprogram Biosciences
Luminai
TextQL
From a Seed Check to Nasdaq
Faeth Therapeutics
Alexis Zamira Maciel promoted to Principal
Shaherose Charania joined as Partner
TextQL
Eric Ries joined as 'Incorruptible' Partner
Alexis Zamira Maciel promoted to Principal